Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated
Open Access
- 17 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 46 (2), 300-307
- https://doi.org/10.1038/bmt.2010.112
Abstract
Blood stream infection (BSI) and acute GVHD (aGVHD) are serious complications of hematopoietic SCT (HSCT). We hypothesized that the two events were not independent of one another. We studied (1) associations between BSI and aGVHD; and (2) the impact of BSI and/or aGVHD on death within 100 days after HSCT, using a retrospective cohort analysis. Risk factor analysis was carried out using multivariable Cox proportional hazards analyses. Of 211 patients who underwent allogeneic HSCT from January 2000 to December 2005 (58% of whom underwent reduced intensity transplantation), 82 (39%) developed BSI. In 49 patients (23%), grade (gr) 2–4 aGVHD occurred. Early BSI was independently associated with an increased occurrence of subsequent aGVHD gr 2–4. CMV seropositivity was independently associated with decreased occurrence of aGVHD. aGVHD gr 2–4 independently predicted subsequent first BSI. Both BSI and aGVHD gr 2–4 were significant independent predictors of death within 100 days after HSCT. There is a strong, independent association between BSI and aGVHD. Potential explanations include the elaboration of cytokines during BSI favoring the development of aGVHD and/or the immunosuppressive treatment of aGVHD favoring the development of BSI. Future studies should be directed at the mechanistic investigations of this association.Keywords
This publication has 49 references indexed in Scilit:
- Graft-versus-host diseaseThe Lancet, 2009
- Biological Advances in Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationTransplantation, 2008
- Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks modelsCritical Care, 2008
- Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in PatientsDigestive Diseases and Sciences, 2007
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantationBone Marrow Transplantation, 2005
- Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host diseaseBone Marrow Transplantation, 2005
- Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningBone Marrow Transplantation, 2004
- PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDYTransplantation, 2004
- A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host diseaseBone Marrow Transplantation, 2004